Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Taltz

PharmaCompass

01

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 1,789

2019 Revenue in Millions : 1,366

Growth (%) : 31

blank

02

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 2,213

2020 Revenue in Millions : 1,789

Growth (%) : 24

blank

03

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 2,482

2021 Revenue in Millions : 2,213

Growth (%) : 12

blank

04

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 2,760

2022 Revenue in Millions : 2,482

Growth (%) : 11

blank

05

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Immunology

Currency : USD

2024 Revenue in Millions : 3,260

2023 Revenue in Millions : 2,760

Growth (%) : 18

blank

06

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Dermatology

Currency : USD

2016 Revenue in Millions : 113

2015 Revenue in Millions : Not Reported

Growth (%) : New Launch

blank

07

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Autoimmune Disorders

Currency : USD

2017 Revenue in Millions : 559

2016 Revenue in Millions : 113

Growth (%) : 394

blank

08

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Autoimmune Disorders

Currency : USD

2018 Revenue in Millions : 937

2017 Revenue in Millions : 559

Growth (%) : 68%

blank

09

Brand Name : Taltz

Ixekizumab

arrow
Pharmex
Not Confirmed

Brand Name : Taltz

arrow
Pharmex
Not Confirmed

Ixekizumab

Main Therapeutic Indication : Immunology

Currency : USD

2019 Revenue in Millions : 1,366

2018 Revenue in Millions : 937

Growth (%) : 46

blank